Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Public health reports ; v. 14, no. 16, April 21, 1899
  • Published Date:
    Apr 21 1899
  • Source:
    Public Health Rep. 14(16):533-579
  • Language:
    English
Filetype[PDF-4.81 MB]


Details:
  • Alternative Title:
    Public Health Rep
  • Subject:
  • Pubmed ID:
    19313612
  • Pubmed Central ID:
    PMCnull
  • Document Type:
    Journal Issue
  • Collection(s):
    Public Health Reports
  • Main Document Checksum:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Estimating the catchment population and incidence of severe acute respiratory infections in a district hospital in Boussé, Burkina Faso
    Personal Author:
    Milucky, Jennifer L; Compaore, Toussaint; Obulbiga, Franck; Cowman, Gretchen; Whitney, Cynthia G; Bicaba, Brice;
    Published Date:
    Jun 2020
    Source:
    J Glob Health. 2020; 10(1)
    Description:
    BackgroundThe primary cause of death in Burkina Faso is lower respiratory tract infections, accounting for 1 in 7 deaths. The Ministry of Health is building surveillance for severe acute respiratory infections (SARI) in four districts. This study sou...
    File Type:
    Filetype[PDF - 516.96 KB]
  2. Burden of influenza-associated respiratory and circulatory mortality in India, 2010-2013
    Personal Author:
    Narayan, Venkatesh Vinayak; Iuliano, A Danielle; Roguski, Katherine; Bhardwaj, Rohit; Chadha, Mandeep; Saha, Siddhartha; Haldar, Partha; Kumar, Rajeev; Sreenivas, Vishnubhatla; Kant, Shashi; Bresee, Joseph; Jain, Seema; Krishnan, Anand;
    Published Date:
    Jun 2020
    Source:
    J Glob Health. 2020; 10(1)
    Description:
    BackgroundInfluenza causes substantial morbidity and mortality worldwide, however, reliable burden estimates from developing countries are limited, including India. We aimed to quantify influenza-associated mortality for India utilizing 2010-2013 nat...
    File Type:
    Filetype[PDF - 845.46 KB]
  3. Effectiveness of Monovalent Rotavirus Vaccine Against Hospitalization With Acute Rotavirus Gastroenteritis in Kenyan Children
    Personal Author:
    Khagayi, Sammy; Omore, Richard; Otieno, Grieven P; Ogwel, Billy; Ochieng, John B; Juma, Jane; Apondi, Evans; Bigogo, Godfrey; Onyango, Clayton; Ngama, Mwanajuma; Njeru, Regina; Owor, Betty E; Mwanga, Mike J; Addo, Yaw; Tabu, Collins; Amwayi, Anyangu; Mwenda, Jason M; Tate, Jacqueline E; Parashar, Umesh D; Breiman, Robert F; Nokes, D James; Verani, Jennifer R;
    Published Date:
    May 23 2020
    Source:
    Clin Infect Dis. 2019; 70(11):2298-2305
    Description:
    BackgroundRotavirus remains a leading cause of pediatric diarrheal illness and death worldwide. Data on rotavirus vaccine effectiveness in sub-Saharan Africa are limited. Kenya introduced monovalent rotavirus vaccine (RV1) in July 2014. We assessed R...
    File Type:
    Filetype[PDF - 8.37 MB]
  4. Impact of the Introduction of Rotavirus Vaccine on Hospital Admissions for Diarrhea Among Children in Kenya: A Controlled Interrupted Time-Series Analysis
    Personal Author:
    Otieno, Grieven P; Bottomley, Christian; Khagayi, Sammy; Adetifa, Ifedayo; Ngama, Mwanajuma; Omore, Richard; Ogwel, Billy; Owor, Betty E; Bigogo, Godfrey; Ochieng, John B; Onyango, Clayton; Juma, Jane; Mwenda, Jason; Tabu, Collins; Tate, Jacqueline E; Addo, Yaw; Britton, Tuck; Parashar, Umesh D; Breiman, Robert F; Verani, Jennifer R; Nokes, D James;
    Published Date:
    May 23 2020
    Source:
    Clin Infect Dis. 2019; 70(11):2306-2313
    Description:
    BackgroundMonovalent rotavirus vaccine, Rotarix (GlaxoSmithKline), was introduced in Kenya in July 2014 and is recommended to infants as oral doses at ages 6 and 10 weeks. A multisite study was established in 2 population-based surveillance sites to ...
    File Type:
    Filetype[PDF - 1.06 MB]
  5. Coming Soon
    Griffithsin Inhibits Nipah Virus Entry and Fusion and Can Protect Syrian Golden Hamsters From Lethal Nipah Virus Challenge
    Personal Author:
    Lo, Michael K; Spengler, Jessica R; Krumpe, Lauren R H; Welch, Stephen R; Chattopadhyay, Anasuya; Harmon, Jessica R; Coleman-McCray, JoAnn D; Scholte, Florine E M; Hotard, Anne L; Fuqua, Joshua L; Rose, John K; Nichol, Stuart T; Palmer, Kenneth E; O’Keefe, Barry R; Spiropoulou, Christina F;
    Published Date:
    May 11 2020
    Source:
    J Infect Dis. 2020; 221(Suppl 4):S480-S492
    Description:
    Nipah virus (NiV) is a highly pathogenic zoonotic paramyxovirus that causes fatal encephalitis and respiratory disease in humans. There is currently no approved therapeutic for human use against NiV infection. Griffithsin (GRFT) is high-mannose oligo...
    Public Access
    Available on:
    May 11, 2021